Maculopapular rash induced by diltiazem: Allergological investigations in four patients and cross reactions between calcium channel blockers

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 11, 2003, Pages 1207-1209

  Cholez, C ^b   Trechot, P ^b   Schmutz, J L ^b   Faure, G ^b   Bene, M C ^b   Barbaud, A ^a  

^a SERVICE DE DERMATOLOGIE   (France)

^b NONE

Author keywords

Calcium channel blockers; Cross reaction; Drug intradermal test; Drug patch test; Drug prick test; Drug skin testing; Lymphocyte activation test

Indexed keywords

AMLODIPINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; BENZOTHIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DILTIAZEM; FELODIPINE; ISRADIPINE; LACIDIPINE; MONOTILDIEM; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; NITRENDIPINE; PHENYLALKYLAMINE; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; CROSS REACTION; DRUG HYPERSENSITIVITY; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; HUMAN; LYMPHOCYTE ACTIVATION; MALE; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; PSORIASIS; PUSTULOSIS; RASH; SKIN TEST; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

CALCIUM CHANNEL BLOCKERS; CROSS REACTIONS; DILTIAZEM; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; SKIN TESTS;

EID: 0242456202     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2003.00222.x     Document Type: Article

References (22)

1. BARBAUD A, GONÇALO M, BRUYNZEEL D, BIRCHER A. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001;45:321-328.
2. KOHLER C, KOLOPP-SARDA MN, DE MARCH-KENNEL A, BARBAUD A, BENE MC, FAURE GC. Sequential assesment of cell cycle S in flow cytometry: a non isotopic method to measure lymphocyte activation in vitro. Anal Cell Pathol 1997;14:51-59.
3. MOORE N, BIOUR M, PAUX G, LOUPIE E, BEGAUD B, BOISMARE F et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985;2:1056-1058.
4. KNOWLES S, GUPTA AK, SHEAR NH. The spectrum of cutaneous reactions associated with diltiazem: three cases and a review of the literature. J Am Acad Dermatol 1998;38:201-206.
5. SOUSA-BASTO A, AZENHA A, DUARTE M, PARDAL-OLIVEIRA F. Generalized cutaneous reaction to diltiazem. Contact Dermatitis 1993;28:44-45.
6. BARBAUD A, TRECHOT P, GILLET-TERVER M, ZANNAD F, SCHMUTZ JL. Investigations immunoallergologiques dans une toxidermie au diltiazem (Tildiem 300 LP). Thérapie 1993;48:499-500.
7. STERN R, KHALSA JH. Cutaneous adverse reactions associated with calcium channel blockers. Arch Intern Med 1989;149:829-832.
8. ROMANO A, PIETRANTONIO F, GACOVICH A et al. Delayed hypersensitivity to diltiazem in two patients. Ann Allergy 1992;69:31-32.
9. KITAMURA K, KANASASHI M, SUGA C, SAITO S, YOSHIDA S, IKEZAWA Z. Cutaneous reactions induced by calcium channel blocker: high frequency of psoriasiform eruptions. J Dermatol 1993;20:279-286.
10. HAMMENTGEN R, LUTZ G, KOHLER U, NITSCH J. Makulopapuloses exanthem bei diltiazem-therapie. Dtsch Med Wschr 1988;113:1283-1285.
11. ODEH M. Exfoliative dermatitis associated with diltiazem. J Toxicol Clin Toxicol 1997;35:101-104.
12. LAMBERT D, DALAC S, BEER F, CHAVANNET P, PORTIER H. Acute generalized exanthematous pustular induced by diltiazem. Br J Dermatol 1988;118:308-309.
13. VICENTE-CALLEJA JM, AGUIRRE A, LANDA N, CRESPO V, GONZALEZ-PEREZ R. Acute generalized exanthematous pustulosis due to diltiazem: confirmation by patch testing. Br J Dermatol 1997;137:837-839.
14. WAKELIN S, JAMES M. Diltiazem-induced acute generalised exanthematous pustulosis. Clin Exp Dematol 1995;20:341-344.
15. JAN V, MACHET L, GIRONET N, MARTIN L, MACHET MC, LORETTE G et al. Acute generalized exanthematous pustulosis induced by diltiazem: value of patch testing. Dermatology 1998;197:274-275.
16. LAHAV M, ARAV R. Diltiazem and thrombopenia. Ann Intern Med 1989; 110:327.
17. DOMINGUEZ EA, HAMILL RJ. Drug induced fever due to diltiazem. Arch Intern Med 1991;151:1869-1870.
18. BARBAUD A, REICHERT-PENETRAT S, TRECHOT P, JACQUIN-PETIT MA, EHLINGER A, NOIREZ V et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998;139:49-58.
19. ZANNAD F, BAILLE N. Les antagonistes calciques. In: GILGENKRANTZ JM, ROYER RJ, ZANNAD F. editors. The rapeutique en pathologie cardio-vasculaire. Paris: Medecine-Sciences Flammarion, 1987: 124-142.
20. KUO M, WINIARSKI N, GARELLA S. Non-thrombocytopenic purpura associated sequentially with nifedipine and diltiazem. Ann Pharmacother 1992;26:1089-1090.
21. BAKER AB, CACCHIONE JG. Dermatologie cross-sensitivity between diltiazem and amlodipine. Ann Pharmacother 1994;28:118-119.
22. BEWLEY A, FEHER M, STAUGHTON R. Erythema multiforme following substitution of amlodipine for nifedipine. Br Med J 1993;307:241.